Cargando…

The role of fecal calprotectin in pediatric disease

Fecal calprotectin (FC) is a calcium- and zinc-binding protein of the S100 family, mainly expressed by neutrophils and released during inflammation. FC became an increasingly useful tool both for gastroenterologists and for general practitioners for distinguishing inflammatory bowel disease (IBD) fr...

Descripción completa

Detalles Bibliográficos
Autor principal: Jeong, Su Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Pediatric Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702112/
https://www.ncbi.nlm.nih.gov/pubmed/30999729
http://dx.doi.org/10.3345/kjp.2019.00059
_version_ 1783445157288345600
author Jeong, Su Jin
author_facet Jeong, Su Jin
author_sort Jeong, Su Jin
collection PubMed
description Fecal calprotectin (FC) is a calcium- and zinc-binding protein of the S100 family, mainly expressed by neutrophils and released during inflammation. FC became an increasingly useful tool both for gastroenterologists and for general practitioners for distinguishing inflammatory bowel disease (IBD) from irritable bowel syndrome. Increasing evidences support the use of this biomarker for diagnosis, follow-up and evaluation of response to therapy of several pediatric gastrointestinal diseases, ranging from IBD to nonspecific colitis and necrotizing enterocolitis. This article summarizes the current literature on the use of FC in clinical practice.
format Online
Article
Text
id pubmed-6702112
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Pediatric Society
record_format MEDLINE/PubMed
spelling pubmed-67021122019-09-03 The role of fecal calprotectin in pediatric disease Jeong, Su Jin Korean J Pediatr Review Article Fecal calprotectin (FC) is a calcium- and zinc-binding protein of the S100 family, mainly expressed by neutrophils and released during inflammation. FC became an increasingly useful tool both for gastroenterologists and for general practitioners for distinguishing inflammatory bowel disease (IBD) from irritable bowel syndrome. Increasing evidences support the use of this biomarker for diagnosis, follow-up and evaluation of response to therapy of several pediatric gastrointestinal diseases, ranging from IBD to nonspecific colitis and necrotizing enterocolitis. This article summarizes the current literature on the use of FC in clinical practice. Korean Pediatric Society 2019-08 2019-03-28 /pmc/articles/PMC6702112/ /pubmed/30999729 http://dx.doi.org/10.3345/kjp.2019.00059 Text en Copyright © 2019 by The Korean Pediatric Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Jeong, Su Jin
The role of fecal calprotectin in pediatric disease
title The role of fecal calprotectin in pediatric disease
title_full The role of fecal calprotectin in pediatric disease
title_fullStr The role of fecal calprotectin in pediatric disease
title_full_unstemmed The role of fecal calprotectin in pediatric disease
title_short The role of fecal calprotectin in pediatric disease
title_sort role of fecal calprotectin in pediatric disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702112/
https://www.ncbi.nlm.nih.gov/pubmed/30999729
http://dx.doi.org/10.3345/kjp.2019.00059
work_keys_str_mv AT jeongsujin theroleoffecalcalprotectininpediatricdisease
AT jeongsujin roleoffecalcalprotectininpediatricdisease